( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
96305.4
89253.3
112738.8
92500.2
Total Expenditure
103631
99930.8
120182.8
102104.4
PBIDT (Excl OI)
-7325.60
-10677.5
-7444
-9604.2
Other Income
30928.9
43828.5
34080.7
41042.3
Operating Profit
23603.3
33151
26636.7
31438.1
Exceptional Items
NA
NA
NA
NA
PBDT
23603.3
33151
26636.7
31438.1
Profit Before Tax
23603.3
33151
26636.7
31438.1
Tax
6089.4
6170.9
4909
7799.4
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
17513.9
26980.1
21727.7
23638.7
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
17513.9
26980.1
21727.7
23638.7
Minority Interest
NA
NA
NA
NA
Shares of Associates
-257.3
1755.3
3578.2
1349.9
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
17256.6
28735.4
25305.9
24988.6
Equity Capital
8772
8772
8772
8772
Reserves
550293.5
528775.3
510101
477819.6
Calculated EPS
9.83
16.37
14.42
14.24
Calculated EPS (Annualised)
39.34
65.51
57.69
56.97
No of Public Share Holdings
308832385
308832385
308832385
308832385
% of Public Share Holdings
17.6
17.6
17.6
17.6
PBIDTM% (Excl OI)
-7.60
-11.96
-6.60
-10.38
PBIDTM%
24.50
37.14
23.62
33.98
PBDTM%
24.50
37.14
23.62
33.98
PBTM%
24.50
37.14
23.62
33.98
PATM%
18.18
30.22
19.27
25.55